21 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 21 separate news trends connected to Statins, spanning June 26, 2026 through October 12, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 188 article observations and 178 source signals, led by Health coverage. Use it to compare how individual events emerged, spread and changed over time.
7 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Cholesterol's reputation takes a hit as cardiologists challenge conventional wisdom.
A one‑time CRISPR infusion slashed LDL cholesterol by about half for a year, sparking debate over its potential to outpace statins.
New safety alerts link common blood‑pressure, statin and iron pills to a surge in fall‑risk drug interactions among seniors.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Common class of drugs linked to lower dementia risk
Early statin therapy after a type‑2 diabetes diagnosis is linked to a 15% dip in dementia cases, sparking debate over preventive use.
A 30 percent cut in heart attacks for seniors puts statins back in the spotlight.
A cholesterol pill may cut dementia risk by 15% for diabetics, sparking debate over a new use for statins.
A world-first clinical trial shows statins can safely reduce heart attacks and strokes in healthy older adults.
A $100 heart scan could help some adults decide whether to start taking statins.
A shingles vaccine may cut dementia risk by nearly a quarter, sparking hopes for a new preventive tool.
New cholesterol guidelines are out, and they may change how you manage your heart health.
A warning has been issued about high-dose statins for high cholesterol patients.
A new study suggests that stopping statins in low-risk seniors may not increase mortality, but experts debate the findings.
New US guidelines have expanded statin eligibility, potentially affecting millions more Americans and young adults managing 'bad' cholesterol.
Updated cholesterol guidelines may expand statin eligibility to more than half of U.S. adults, including younger and lower-risk individuals.
New research may explain why statins cause muscle pain, potentially reshaping how these common drugs are prescribed.
New research identifies a possible metabolic cause for muscle pain associated with statin cholesterol medications.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
New Oxford research and a predictive calculator confirm that serious muscle side effects from statins are extremely rare for most patients.